December 6, 2023 – [New Castle, Delaware] – Lab Bioreagents is excited to announce its expanded capability to supply disease-specific matrices to support bioanalytical assays for clinical PK, immunogenicity, and biomarker studies. This new offering demonstrates Lab Bioreagents' dedication to delivering comprehensive solutions that accelerate drug development and clinical research. 

 

Advancing Drug Development with Specialized Matrices 

Disease-specific matrices, including serum, plasma, and cerebrospinal fluid, are crucial for developing and validating bioanalytical assays capable of detecting analytes in target patient populations. Lab Bioreagents now offers an extensive selection of matrices sourced from patients with conditions spanning neurology, oncology, infectious diseases, and cardiology.  

 

"Obtaining disease-specific matrices can be challenging, time-consuming, and costly, creating barriers to the development of precise bioanalytical assays. At Lab Bioreagents, we are changing that. Our focus is on delivering high-quality matrices on time and at competitive costs," said David Liu, CEO of Lab Bioreagents. 

 

Key Features of the Disease-Specific Matrix Supply 

  • Wide Selection: Blood and CSF matrices sourced from patients with diverse diseases, including autoimmune disorders, cancer, metabolic conditions, and infections. 

  • Regulatory Compliance: All matrices are collected under strict ethical and regulatory guidelines, ensuring high quality and full traceability. 

  • Tailored Solutions: Customized matrix solutions are available to meet specific assay requirements and study needs. 

 

Supporting Precision in Bioanalytical Science 

The addition of disease-specific blood matrices enhances Lab Bioreagents' robust bioanalytical portfolio, enabling researchers to develop and validate assays with greater relevance and scientific rigor. These matrices are ideal for assay development, method validation, and regulatory submissions, ensuring that bioanalytical studies meet the highest standards of precision and compliance. 

 

To learn more about Lab Bioreagents' disease-specific matrix supply services and how they can support your bioanalytical needs, visit www.labbioreagents.com or contact us at sales@labbioreagents.com.